1 of 1
Story summary
- XtalPi Holdings, an AI-driven drug research company, expects its first annual profit in 2025 of at least 100 million yuan after a 1.5 billion yuan loss in 2024.
- Revenue for the year ending December rose to at least 780 million yuan, up 193% from prior year, driven by robotics and drug discovery with gains on financial assets exceeding 500 million yuan.
- XtalPi's shares fell 2% to HK$9.54.
